Treatment Pattern in Patients with Stage III Non-Small-Cell Lung Cancer (NSCLC) in South China

被引：0
作者：
Au, J. S. [1 ]
机构：
[1] Hong Kong Adventist Hosp Oncol Ctr, Hong Kong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
multidisciplinary approach; Immunotherapy; stage III nonsmall cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P09.40
引用
收藏
页码：S308 / S308
页数：1
相关论文
共 50 条
[21]   Systematic review: Soluble immunological biomarkers in advanced non-small-cell lung cancer (NSCLC) [J].
Mildner, Finn ;
Sopper, Sieghart ;
Amann, Arno ;
Pircher, Andreas ;
Pall, Georg ;
Koeck, Stefan ;
Naismith, Erin ;
Wolf, Dominik ;
Gamerith, Gabriele .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 153
[22]   Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC) [J].
Del Giudice, Teresa ;
Staropoli, Nicoletta ;
Tassone, Pierfrancesco ;
Tagliaferri, Pierosandro ;
Barbieri, Vito .
CANCERS, 2024, 16 (10)
[23]   Concurrent versus sequential immunotherapy with chemoradiotherapy for unresectable stage III non-small-cell lung cancer: a retrospective study [J].
Zhou, Meng-Xi ;
Fan, Wen-Jie ;
Zhang, Ning ;
Zhu, Li-Yang ;
Wang, Hong-Yan .
FRONTIERS IN ONCOLOGY, 2025, 14
[24]   New perspectives in the treatment of non-small cell lung cancer (NSCLC) [J].
Brockmoeller, Juergen ;
Junker, Klaus ;
Multhoff, Gabriele .
ONKOLOGIE, 2006, 29 :25-28
[25]   A Review of the Current Approach and Treatment Landscape for Stage III Non-Small Cell Lung Cancer [J].
Sridhar, Arthi ;
Khan, Hina ;
Yohannan, Binoy ;
Chan, Kok Hoe ;
Kataria, Nilansh ;
Jafri, Syed Hasan .
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
[26]   Real-world KINDLE-Latin America subset data on treatment patterns and clinical outcomes in patients with stage III non-small-cell lung cancer [J].
Marcelo Martin, Claudio ;
Puello-Guerrero, Adrian ;
Alberto Mas-Lopez, Luis ;
Campos-Gomez, Saul ;
Orlando-Orlandi, Francisco J. ;
Tejado Gallegos, Luis Fernando ;
Huggenberger, Reto .
CANCER MEDICINE, 2023, 12 (02) :1247-1259
[27]   Neoadjuvant Chemoradiotherapy for Stage iii Non-Small Cell Lung Cancer [J].
Sher, David J. .
FRONTIERS IN ONCOLOGY, 2017, 7
[28]   The role of biomarkers in stage III non-small cell lung cancer [J].
Rosell, Rafael ;
Gonzalez-Cao, Maria ;
Ito, Masaoki ;
Santarpia, Mariacarmela ;
Aguilar, Andres ;
Codony-Servat, Jordi .
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2023, 17 (06) :469-480
[29]   Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study [J].
Kim, Dong-Wan ;
Cho, Byoung Chul ;
Pachipala, Krishna ;
Kim, Sang-We ;
Wang, Chih-Liang ;
Chang, Gee -Chen ;
Ahn, Myung-Ju ;
Alvarez, Rosa ;
Chiu, Chao-Hua ;
Trigo, Jose ;
Estival, Anna ;
Karam, Sana D. ;
O'Brien, Cathy ;
Gowda, Hema ;
Jiang, Haiyi ;
Bauman, Julie E. .
LUNG CANCER, 2024, 190
[30]   Interim Analysis of Neoadjuvant Chemoradiotherapy and Durvalumab for Potentially Resectable Stage III Non-Small Cell Lung Cancer (NSCLC) [J].
Hong, M. H. ;
Ahn, B. ;
Kim, H. R. ;
Lim, S. M. ;
Lee, S. ;
Park, S. Y. ;
Lee, C. Y. ;
Lee, J. G. ;
Kim, D. J. ;
Lee, S. H. ;
Yoon, H. I. ;
Lee, C. G. ;
Cho, J. ;
Shim, H. S. ;
Kim, T. ;
Cho, B. C. .
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) :S194-S195
12345